InvestorsHub Logo

Solar_Express

03/28/20 3:27 PM

#11861 RE: Itchy palm #11860

Authors Comment
Thomas Barnard
Comments174 | + Follow
Author’s reply »
Leronlimab may be useful for extreme cases with the cytokine storms, but many of us older folks are hoping that companies like Generex (GNBT) will stay the course because the epidemiologists say this disease is now out in the general population from here forward. Generex's Ii-key technology may be one of the best for vaccine development, which could save us from catching one of these horrible cases.

https://seekingalpha.com/article/4334730-cytodyn-may-be-one-of-first-biotechs-to-drug-helps-against-covidminus-19

bwolfy2002

03/28/20 6:13 PM

#11863 RE: Itchy palm #11860

Since I’m like 60/40 CYDY/GNBT I’d love for lero to treat and li-key to vaccinate. Then both to work in cancer....